Mirum Pharmaceuticals Inc. – Investors and Politicians Who Own It
MIRM
Investors who own it
7 tracked investors, $238.2M in shares, each from their latest 13F.
| Investor | Value | Share of portfolio |
|---|---|---|
Mark LampertBVF Partners, Q2 2026 | $123.6M | 3.16% |
Julian i Felix BakerBaker Bros. Advisors, Q2 2026 | $52.2M | 0.26% |
Peter KolchinskyRA Capital Management, Q2 2026 | $37.3M | 0.32% |
Joseph EdelmanPerceptive Advisors, Q2 2026 | $13.5M | 0.20% |
Anand ParekhAlyeska Investment Group, Q2 2026 | $8.7M | 0.02% |
Polen CapitalQ2 2026 | $2.4M | 0.02% |
Daniel SchneebergerADAR1 Capital Management, Q2 2026 | $456.6K | 0.02% |
Politicians who own it
Estimated from annual disclosures and trades; values are rough estimates.
No member of Congress is estimated to hold this stock.
Investors buying and selling
| Investor | Action | Shares now |
|---|---|---|
| Mark Lampert | Reduced −33% | 1,056,027 |
| Joseph Edelman | New | 115,391 |
| Anand Parekh | Added +117% | 73,959 |
| Polen Capital | Added +1.8% | 20,899 |
| Farallon Capital Management | Sold out | 0 |
| Daniel Schneeberger | Reduced −37% | 3,900 |
Politicians trading it
Latest Congress trades disclosed under the STOCK Act; amounts are ranges.
No disclosed Congress trades in this stock.